DelveInsight's Short-Acting Insulin Market Insights report provides the current and forecast market analysis, individual ...

The short-acting insulin market is set for substantial growth, driven by rising diabetes prevalence, technological ...

Key drivers include technological advancements and evolving healthcare policies. The global market for short-acting insulin ...

Clinical trials of a new, once-a-week insulin have shown that it controls blood sugar as well as daily injections of an ...

The latest clinical trial results from Eli Lilly show the drug manufacturer's once-weekly insulin injection is just as ...

Insulin, produced by the pancreas, regulates blood glucose by facilitating its entry into cells. Various types of insulin are ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

One example is semaglutide, more commonly known as the two branded weight-loss drugs Ozempic and Wegovy. These were among the ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

The global rapid-acting insulin market is expected to grow at a CAGR of 4.75% and reach US$ 11.17 billion by 2032, from US$ 7.36 billion in 2023. The market is mainly driven by growth rate of diabetes ...

Altitude changes during commercial flights may affect the blood glucose levels of people with type 1 diabetes who are treated ...

The growing incidence of diabetes, driven by sedentary lifestyles and poor dietary habits, has heightened the need for insulin therapy to effectively control blood glucose levels. Additionally ...